【Strength】20mcg/dose×200doses 【Brand】JEWIM or OEM 【Indication】It is indicated for the regular treatment of reversible bronchospasm associated with chronic obstructive pulmonary disease (COPD) and chronic asthma. 【Quality Standard】Current BP standard 【GMP Approval】Australia TGA GMP 【Packing】1piece/box, 300 boxes/carton 【MOQ】5000 pieces
Repono】Copia infra 30°C.Tutela a gelu et solis dirige.
Package】Inhaler complectens aluminium canistram obsignatum valvae metering, actuatoris et pilei pulvisculi, 1 canistri per pixidem.
【Fasciae vita】XXXVI mensibus
Qualitativa et quantitatis compositio Unaquaeque theca praebet 200 actiones.Post priming, quaelibet actio inhalatoris 21 mcg ipratropii bromide monohydratorum e valvula liberat et 17 mcg ipratropii bromide monohydratorum ab actuatore
Therapeutica indicia Ipratropium Pressurized Inspiratio indicatur ad tractationem regularem convertitur bronchospasmum cum morbo pulmonis obstructivo chronico (COPD) et suspiriis longis.
Posologia modumque administrationis Inspiratione pro usu.
Adulti (including senibus): Fere 1 vel 2 ter vel quater cotidie inflant, quamvis aliqui aegroti usque ad egeant. 4 inflat in tempore ad obtinendum maximum beneficium in teneris curandis.
Pueri: 6-12 annis: Fere 1 vel 2 ter cotidie inflat. Sub 6 annis: Solet 1 ter agitas cotidie. Ut ut inhalator recte adhibetur, administratio sit praeerant adulto.
Commendatur dosis non exceditur. Si therapia notabilem emendationem non gignit, si condicio aegri accipit peius vel si responsio ad tractationem reducta patebit, consilium medicinae esse debet quaesivit.In casu acuti vel celerius dyspnoea crescente (inspirandi difficultas) a medicus statim consulendus est.
SPC ad Ipratropium Pressurized Inhalation.pdf
